GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bluemtec Co Ltd (XKRX:439580) » Definitions » Debt-to-Equity

Bluemtec Co (XKRX:439580) Debt-to-Equity : 0.00 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bluemtec Co Debt-to-Equity?

Bluemtec Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩0 Mil. Bluemtec Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩0 Mil. Bluemtec Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩43,696 Mil. Bluemtec Co's debt to equity for the quarter that ended in Mar. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Bluemtec Co's Debt-to-Equity or its related term are showing as below:

XKRX:439580' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.67   Med: 1.16   Max: 9.3
Current: 0.7

During the past 3 years, the highest Debt-to-Equity Ratio of Bluemtec Co was 9.30. The lowest was 0.67. And the median was 1.16.

XKRX:439580's Debt-to-Equity is ranked worse than
60.99% of 546 companies
in the Healthcare Providers & Services industry
Industry Median: 0.48 vs XKRX:439580: 0.70

Bluemtec Co Debt-to-Equity Historical Data

The historical data trend for Bluemtec Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bluemtec Co Debt-to-Equity Chart

Bluemtec Co Annual Data
Trend Dec20 Dec21 Dec22
Debt-to-Equity
-6.72 -0.51 9.30

Bluemtec Co Quarterly Data
Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial 9.30 0.73 1.59 0.67 -

Competitive Comparison of Bluemtec Co's Debt-to-Equity

For the Pharmaceutical Retailers subindustry, Bluemtec Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bluemtec Co's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bluemtec Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Bluemtec Co's Debt-to-Equity falls into.


Bluemtec Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Bluemtec Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(4283.717 + 6671.8) / 1178.056
=9.30

Bluemtec Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 43696.226
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bluemtec Co  (XKRX:439580) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Bluemtec Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Bluemtec Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Bluemtec Co (XKRX:439580) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bluemtec Co Ltd (XKRX:439580) » Definitions » Debt-to-Equity
Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 322-2, 322-2A, 184, Jungbu-daero, Giheung-gu , Gyeonggi-do, 1612, 1613, 1614, 1615 Yeongdeok-dong, Hicks U Tower, Yongin-si, KOR
Website
https://www.bluemtec.co.kr
Bluemtec Co Ltd is a company whose main business is selling prescription drugs through an e-commerce platform. It operates two pharmaceutical distribution platforms, BluePharmKorea targeting hospitals and clinics, and KoolPharm targeting pharmacies and provide IT services to operate and advance these two platforms. In addition, they are operating BlueLabs, which provides services and website development for pharmaceutical companies and medical institutions.

Bluemtec Co (XKRX:439580) Headlines

No Headlines